+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid udca in chronic hepatitis a double blind multicenter clinical trial



Ursodeoxycholic acid udca in chronic hepatitis a double blind multicenter clinical trial



Gastroenterology 100(5 Part 2): 719




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144948

Download citation: RISBibTeXText


Related references

Ursodeoxycholic acid udca for symptomatic primary biliary cirrhosis pbc a double blind multicenter trial. Journal of Hepatology 9(Suppl. 1): S44, 1989

Ursodeoxycholic acid udca for treatment of primary biliary cirrhosis pbc interim analysis of a double blind multicenter randomized trial. Hepatology 10(4): 639, 1989

Effect of ursodeoxycholic acid udca treatment in patients with hypertransaminasemia a double blind clinical trial. Gastroenterology 94(5 Part 2): A524, 1988

Effects of ursodeoxycholic acid (UDCA) on serum liver damage indices in patients with chronic active hepatitis. A double-blind controlled study. European Journal of Clinical Pharmacology 40(5): 473-476, 1991

Interim evaluation of a prospective double-blind trial of ursodeoxycholic acid versus UDCA plus prednisolone in primary biliary cirrhosis. Gastroenterology 104(4 Suppl. ): A938, 1993

Ursodeoxycholic acid udca in chronic active hepatitis results of a controlled trial. Journal of Hepatology 13(Suppl. 2): S104, 1991

Efficacy and safety of ursodeoxycholic acid in primary, type IIa or IIb hypercholesterolemia: a multicenter, randomized, double-blind clinical trial. Atherosclerosis 203(2): 479-482, 2009

A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis C. Gut 56(12): 1747-1753, 2007

Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. Interim analysis of a double-blind multicentre randomized trial. The UDCA-PBC Study Group. Journal of Hepatology 11(1): 16-21, 1990

Double blind controlled trial of ursodeoxycholic acid udca versus placebo in the treatment of reflux gastritis in patients not submitted to gastric surgery. Acta Endoscopica 19(4): 251-257, 259-260, 1989

Safe use of ursodeoxycholic acid in the treatment of dyspeptic symptoms in patients with chronic active hepatitis: a double-blind controlled trial. Journal of International Medical Research 10(4): 278-282, 1982

The effect of ursodeoxycholic acid on serum enzymes and liver histology in patients with chronic active hepatitis. A 12-month double-blind, placebo-controlled trial. Journal of Hepatology 20(3): 315-320, 1994

Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis. Hepatology 23(6): 1484-1490, 1996

Ursodiol in the long-term treatment of chronic hepatitis: a double-blind multicenter clinical trial. Journal of Hepatology 19(3): 459-464, 1993

The Canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 19(5): 1149-1156, 1994